Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease

Department of Medicine, State University of New York, Stony Brook.

The Northwick Park Heart Study found that elevation of factor VII in middle-aged subjects was an independent risk factor for subsequent ischemic heart disease. The present study was designed to determine whether factor VII elevation is present at a younger age and whether zymogen or activated factor VII is responsible for this elevation. A group of 20 asymptomatic first degree relatives (mean age 34.9 years) of patients with premature ischemic heart disease were compared with 15 age-matched normal subjects at low risk of ischemic heart disease and 15 older subjects with established ischemic heart disease (mean age 49.7 years). Factor VII procoagulant, coupled amidolytic and antigenic assays, as well as fasting serum triglyceride and cholesterol assays, were performed on all three groups. Factor VII antigen and coagulant activity was significantly elevated in first degree relatives, as was factor VII antigen in the patients with ischemic heart disease. The increased factor VII level in these subjects was caused by elevated factor VII zymogen, not activated factor VII. The results of this study, combined with those of previous studies, suggest that factor VII may be a useful additional marker of the risk for ischemic heart disease and merits further investigation.

This article has been cited by other articles:

				G. D.O. Lowe, A. Rumley, A. D. McMahon, I. Ford, D. St. J. O'Reilly, C. J. Packard, and for the West of Scotland Coronary Prevention Study Interleukin-6, Fibrin D-Dimer, and Coagulation Factors VII and XIIa in Prediction of Coronary Heart Disease Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1529 - 1534. [Abstract] [Full Text] [PDF]

				A. C. Sposito and M. J. Chapman Statin Therapy in Acute Coronary Syndromes: Mechanistic Insight Into Clinical Benefit Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1524 - 1534. [Abstract] [Full Text] [PDF]

				J. B. Braunstein, D. W. Kershner, P. Bray, G. Gerstenblith, S. P. Schulman, W. S. Post, and R. S. Blumenthal Interaction of Hemostatic Genetics With Hormone Therapy : New Insights To Explain Arterial Thrombosis in Postmenopausal Women Chest, March 1, 2002; 121(3): 906 - 920. [Abstract] [Full Text] [PDF]

				D. A. Lane and P. J. Grant Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease Blood, March 1, 2000; 95(5): 1517 - 1532. [Full Text] [PDF]

				R. P. Tracy, A. M. Arnold, W. Ettinger, L. Fried, E. Meilahn, and P. Savage The Relationship of Fibrinogen and Factors VII and VIII to Incident Cardiovascular Disease and Death in the Elderly : Results From the Cardiovascular Health Study Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1776 - 1783. [Abstract] [Full Text] [PDF]

				F. M. van 't Hooft, A. Silveira, P. Tornvall, A. Iliadou, E. Ehrenborg, P. Eriksson, and A. Hamsten Two Common Functional Polymorphisms in the Promoter Region of the Coagulation Factor VII Gene Determining Plasma Factor VII Activity and Mass Concentration Blood, May 15, 1999; 93(10): 3432 - 3441. [Abstract] [Full Text] [PDF]

				R. Junker, J. Heinrich, H. Schulte, J. van de Loo, and G. Assmann Coagulation Factor VII and the Risk of Coronary Heart Disease in Healthy Men Arterioscler. Thromb. Vasc. Biol., August 1, 1997; 17(8): 1539 - 1544. [Abstract] [Full Text]

				H. Philippou, A. Adami, R. A. Amersey, P. J. Stubbs, and D. A. Lane A Novel Specific Immunoassay for Plasma Two-Chain Factor VIIa: Investigation of FVIIa Levels in Normal Individuals and in Patients With Acute Coronary Syndromes Blood, February 1, 1997; 89(3): 767 - 775. [Abstract] [Full Text] [PDF]

				D. Green, M. A. Chamberlain, K. J. Ruth, A. R. Folsom, and K. Liu Factor VII, Cholesterol, and Triglycerides: The CARDIA Study Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 51 - 55. [Abstract] [Full Text]

				R. Kapur, C. J. Hoffman, V. Bhushan, and M. B. Hultin Postprandial Elevation of Activated Factor VII in Young Adults Arterioscler. Thromb. Vasc. Biol., November 1, 1996; 16(11): 1327 - 1332. [Abstract] [Full Text]

				R. P. Tracy, E. G. Bovill, D. Yanez, B. M. Psaty, L. P. Fried, G. Heiss, M. Lee, J. F. Polak, and P. J. Savage Fibrinogen and Factor VIII, but Not Factor VII, Are Associated With Measures of Subclinical Cardiovascular Disease in the Elderly : Results From the Cardiovascular Health Study Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1269 - 1279. [Abstract] [Full Text]

				E. Moor, A. Silveira, F. van't Hooft, A. M. Suontaka, P. Eriksson, M. Blomback, and A. Hamsten Coagulation Factor VII Mass and Activity in Young Men With Myocardial Infarction at a Young Age : Role of Plasma Lipoproteins and Factor VII Genotype Arterioscler. Thromb. Vasc. Biol., May 1, 1995; 15(5): 655 - 664. [Abstract] [Full Text]